Metsera, Inc. raised $215 million in a Series B funding round led by Wellington Management and Venrock Healthcare Capital Partners to advance its clinical-stage portfolio of peptide therapies.
Amount Raised
$215 Million
Round Type
Series B
Investors
Description
Metsera, Inc. has successfully closed a $215 million Series B financing round to further accelerate its innovative portfolio aimed at treating obesity and metabolic diseases. The round was backed by prominent investors including Wellington Management and Venrock Healthcare Capital Partners, alongside several new and existing investors.
Quick answer
Metsera raised $215 Million in a Series B round, dated November 13, 2024. Investors: GV, Alpha Wave Ventures, ARCH Venture Partners, Newpath Partners, Venrock Healthcare Capital Partners, Wellington Management, T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc.
- How much did Metsera raise?
- Metsera raised $215 Million in a Series B round on November 13, 2024.
- Who invested in Metsera?
- GV, Alpha Wave Ventures, ARCH Venture Partners, Newpath Partners, Venrock Healthcare Capital Partners, Wellington Management, T. Rowe Price Associates, Inc. and T. Rowe Price Investment Management, Inc. are named as investors in this round.
- What does Metsera do?
- Metsera is a weight-loss drug developer founded in 2022 by venture capital firm ARCH Venture and investment firm Population Health Partners.
- Where is Metsera based and how big is it?
- Fundz records about 11 employees.
- Who are the decision-makers at Metsera?
- Fundz holds 1 contact at Metsera. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Metsera that raised within 45 days of this round, from Fundz verified event records.
- FOXO Technologies raised $100K on December 27, 2024.
- MilkMate raised $1.7M on December 27, 2024.
- QTREX Quantum Ltd raised $8.3M on December 27, 2024.
- Psyence Group raised $2M (Seed) on December 27, 2024.
- AusperBio raised $73M (Series B) on December 27, 2024.
- Lazurite raised $1.7M (Seed) on December 26, 2024.
Who to call at Metsera, and when
A new round usually means Metsera is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Metsera raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Metsera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Metsera. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Metsera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMetsera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.